Risk of progression differs in high risk and low risk cases when surgery is omitted Ductal carcinoma in situ (DCIS) is a non-obligate precursor lesion of invasive breast cancer. Since the ...

Cancer is the greatest cause of mortality in the world wherein; Breast Invasive Ductal Carcinoma (IDC) is the second leading cause of death among women. Computer-assisted diagnostic (CAD) systems ...

Researchers are hoping to find new ways to predict when an early form of breast cancer is likely to progress and develop new treatments for those at risk, thanks to new funding from Breast Cancer Now.

As a teen, 'Inside Edition' correspondent Alison Hall hated her small breasts. Cancer took them from her at age 32, and she ...

Characterizing Spatial Variability of Soil Organic Carbon Through Improved Machine-Learning Modeling With In Situ Data Resampling: A Case Study in Alaska Abstract: Sparse and unevenly distributed soil ...

Langley Perer, a beloved Hollywood manager and producer, died June 25, 2025 following a four-year battle with cancer. She was ...

ASCO 2025 phase 1b/2 study assessing 9MW2821, nectin-4 antibody drug conjugate, toripalimab in treatment-naïve patients, locally advanced or metastatic urothelial carcinoma.

HER2 tumor marker tests are used to determine whether breast cancer is HER2 positive or negative. A person is a candidate for ...

A West Lothian woman who received a breast cancer diagnosis out of the blue is taking on a marathon-length moonlit challenge.

Have you ever heard about a cancer that is "in situ"? There's a reason why it's called that -- and why it's the kind of ...

Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation WEE1 Inhibitor, APR-1051, in HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in ...

Objective: to analyze the relation of anatomopathological features and axillary involvement in cases of invasive ductal carcinoma. Methods: this is a cross-sectional study of 220 breast cancer ...